CEP-1347CEP-1347 - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-10412.804-HY-10412804-HY-10412Business & Industrial > Science & LaboratoryCEP-1347
Gentaur
EUR12027-02-22

CEP-1347

CAT:
804-HY-10412
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
CEP-1347 - image 1

CEP-1347

  • Description:

    CEP-1347 is an inhibitor of the JNK/SAPK pathway with neuroprotective effects. CEP-1347 blocks JNK1 activation induced by members of the mixed lineage kinase (MLK) family (MLK3, MLK2, MLK1, dual leucine zipper kinase, and leucine zipper kinase) . As an inhibitor of MDM4, CEP-1347 can more effectively inhibit the growth of glioma cells expressing wild-type p53[1][2][3][4][5][6].
  • Product Name Alternative:

    KT7515
  • UNSPSC:

    12352005
  • Target:

    JNK; MDM-2/p53; Mixed Lineage Kinase
  • Type:

    Reference compound
  • Related Pathways:

    Apoptosis; MAPK/ERK Pathway
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/cep-1347.html
  • Purity:

    98.50
  • Solubility:

    10 mM in DMSO
  • Smiles:

    C[C@]12N3C4=C(C5=CC(CSCC)=CC=C53)C(CNC6=O)=C6C(C7=C8)=C4N([C@@H](C[C@]2(O)C(OC)=O)O1)C7=CC=C8CSCC
  • Molecular Formula:

    C33H33N3O5S2
  • Molecular Weight:

    615.76
  • References & Citations:

    [1]Saporito MS, Hudkins RL, Maroney AC. Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases. Prog Med Chem. 2002;40:23-62. |[2]Mitobe Y, Nakagawa-Saito Y, Togashi K, et al. CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma Cells. Anticancer Res. 2022;42 (10) :4727-4733. |[3]Mitobe Y, Suzuki S, Nakagawa-Saito Y, et al. The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo. Biomedicines. 2023;11 (7) :1967.|[4]Maroney AC, Finn JP, Connors TJ, et al. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem. 2001;276 (27) :25302-25308. |[5]Maroney AC, et al. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci. 1998;18 (1) :104-111. |[6]Wagner AC, et al. EP-1347 inhibits caerulein-induced rat pancreatic JNK activation and ameliorates caerulein pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2000;278 (1) :G165-G172.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C, 3 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Phase 3
  • Isoform:

    JNK1
  • CAS Number:

    [156177-65-0]